FDA Inspection
AbbVie Bioresearch CenterAbbVie Bioresearch Center – FDA Inspection, May 24, 2018
Record Details
This FDA Inspection record concerns AbbVie Bioresearch Center, with an inspection on May 24, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · af6c0040-d422-4837-951e-f4145a5230be
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1056813
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of AbbVie Bioresearch Center
12| Date | Classification | Office | Project area |
|---|---|---|---|
| December 16, 2025 | Not classified | New England District Office | |
| September 5, 2025 | Not classified | New England District Office | |
| January 30, 2024 | Not classified | New England District Office | |
| November 18, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 11, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AbbVie Bioresearch Center
- FDA Inspection 1295502 - 2025-12-16
- FDA Inspection 1272372 - 2025-09-05
- FDA Inspection 1252835 - 2024-01-30
- FDA Inspection 1113080 - 2019-11-18
- FDA Inspection 1010336 - 2017-04-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.